Absorbable Hemostat (V2),Absorbable Hemostat (V2)
N/a
BHOPAL, MADHYA PRADESH
Progress
RAQuantity
250
Bid Type
Two Packet Bid
The Municipal Corporation Of Delhi (MCD), based in NEW DELHI, DELHI, invites bids for Absorbable Hemostat (V2). The tender seeks a medically certified hemostatic product with CDSCO approval, batch test reports, and OEM after-sales support. Key quantities and total contract value are not disclosed in the data provided. Bidders must comply with the option clause allowing up to 25% quantity variation and adhere to safety mandates for work in high-risk environments. Special emphasis is placed on regulatory compliance, including MDR 2017 amendments and proper licensing. The tender foregrounds supplier qualification through complete certifications and advanced sample approval, ensuring product equivalence to the buyer’s framework prior to bulk supply. The procurement focuses on medical-grade hemostats suitable for emergency and operative use, with explicit requirements around shelf life and packaging. A strong differentiator is the requirement for a registered Indian office for OEM support if the product is imported, ensuring after-sales service within India. This tender emphasizes compliance, traceability, and risk management in public-health procurement.
Product: Absorbable Hemostat (V2)
Composition: 100% enumerated material
Regulatory: MDR 2017 compliance; CDSCO approval
Licenses: Medical Device license under Drugs and Cosmetics Act 1940
Batch Testing: Test report per MDR 2017 for each batch
Dimensions: Width ±0.5 inch; Length ±0.5 inch
Shelf Life: Minimum shelf life from manufacture date
Advance Sample: 5 samples required for buyer approval within 5 days of award
Packing: Type of packing as specified by buyer
Option Clause enables ±25% quantity variation and pro-rated delivery time
Imported products require Indian OEM presence for after-sales service
Advance sample approval process precedes bulk manufacturing and supply
Payment terms to be defined in contract; compliance with delivery milestones and LD applicable per schedule
Delivery periods commence from last date of original/extended delivery order; option-based extensions with minimum 30 days
LD provisions may apply for non-compliance or delays; details to be provided in contract
Experience in supplying medical devices compliant with MDR 2017
Registered Indian OEM or authorized seller for imported products
Valid CDSCO licenses and batch testing capabilities
Main Document
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS
N/a
BHOPAL, MADHYA PRADESH
All India Institute Of Medical Sciences (aiims)
SOUTH DELHI, DELHI
Sree Chitra Tirunal Institute For Medical Sciences And Technology (sctimst)
THIRUVANANTHAPURAM, KERALA
Sree Chitra Tirunal Institute For Medical Sciences And Technology (sctimst)
Sree Chitra Tirunal Institute For Medical Sciences And Technology (sctimst)
THIRUVANANTHAPURAM, KERALA
Tender Results
Loading results...
| Category | Specification | Requirement |
|---|---|---|
| GENERAL | Product Description | Absorbable Hemostat |
| PRODUCT INFORMATION | Composition of Material (made of 100% of the enumerated material) | Oxidized Regenerated Cellulose (ORC) |
| PRODUCT INFORMATION | Fully Absorb-able as approved by CDSCO | Yes |
| PRODUCT INFORMATION | Complete Absorption period | 7 to 14 Days |
| PRODUCT INFORMATION | Time to achieve complete hemostatis | 1 to 5 minutes |
| PRODUCT INFORMATION | Width (±0.5 inch) | 2 inch |
| PRODUCT INFORMATION | Length (±0.5 inch) | 3 inch |
| PRODUCT INFORMATION | Quantity for Powdered Hemostat | NA |
| PACKAGING | Type of Packing | Moisture Proof Packing |
| CERTIFICATIONS | Compliance to Medical Device Rule (MDR) 2017 as amended till date | Yes |
| CERTIFICATIONS | Availability of valid medical device license for the product issued from the competent authority defined under Drugs and Cosmetic Act 1940 and Rules made there under as amended till date | Yes |
| CERTIFICATIONS | Manufacturer Facility Certification | ISO:13485 (Latest) |
| CERTIFICATIONS | Availability of Test Report for each supplied batch/product as per Medical Device Rule (MDR) 2017 as amended till date | Yes |
| CERTIFICATIONS | Submission of all necessary certifications, licenses and test reports to the buyer at the time of bid submission or along with supplies as per buyer requirement | Yes |
| SHELF LIFE | Shelf life in months from the date of manufacture | 36, 48, 60 Or higher |
| SHELF LIFE | Minimum shelf life of the product at the time of delivery to the consignee | 3/4 th of Total Shelf Life |
| ADVANCE SAMPLE | Agree to provide advance sample of the product for buyer's approval after award of contract and before commencement of supply in case of bidding | Yes |
GST registration certificate
PAN card
Experience certificates showing prior similar medical device supply
Financial statements (last 3 years) and bank statements
EMD/Security deposit submission details
Technical bid documents and compliance certificates
OEM authorization letter (for non-native manufacturers)
CDSCO/MDR related licenses and batch test reports
Manufacturer Facility Certification
Product-specific test reports for each batch
Start
06-Dec-2025, 10:00 am
End
08-Dec-2025, 10:00 am
Duration: 48 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
These are the final prices after the reverse auction event. Prices may be lower than initial bids.
| Rank | Seller | Final Price | Item |
|---|---|---|---|
| L1 | AEGIS LIFESCIENCES PRIVATE LIMITED Under PMA Winner | ₹87,925 | Item Categories : Absorbable Hemostat (V2) |
| L2 | DIKSHA MEDICOS Under PMA | ₹88,025 | Item Categories : Absorbable Hemostat (V2) |
| L3 | PANKAJ PHARMA Under PMA | ₹3,15,000 | Item Categories : Absorbable Hemostat (V2) |
🎉 L1 Winner
AEGIS LIFESCIENCES PRIVATE LIMITED Under PMA
Final Price: ₹87,925
Key insights about DELHI tender market
Bidders must submit GST, PAN, experience certificates, financial statements, EMD, OEM authorizations, and CDSCO MDR 2017 licenses. Include batch test reports for each lot and advance sample approval within 5 days of contract award. Ensure Indian OEM presence for imported products and comply with the 25% option clause.
Submit CDSCO MDR 2017 compliance certificates, Medical Device license under the Drugs and Cosmetics Act, Manufacturer Facility Certification, and batch test reports. Include GST, PAN, experience certificates, financial statements, and OEM authorization if applicable.
Product must meet Width ±0.5 inch and Length ±0.5 inch. Packaging type should be specified in the contract. Ensure packaging meets shelf-life and handling requirements for medical devices.
Submit 5 advance samples within 5 days of award. The buyer will approve or specify modifications within 5 days. If delayed by the buyer, the delivery schedule will be adjusted without LD; bulk supply must conform to approved sample.
The purchaser may increase/decrease the quantity up to 25% of bid quantity. Extended delivery time is calculated as ( Increased quantity ÷ Original quantity ) × Original delivery period, with a minimum of 30 days.
Products must be MDR 2017 compliant, CDSCO approved, with valid medical device licenses under the Drugs and Cosmetics Act, and batch test reports for each supply lot.
Imported products are eligible only if the OEM has a registered Indian office for after-sales service. Provide an OEM authorization and local service support details as part of bid submission.
Delivery period is reset to account for the buyer’s delay in sample approval. No liquidated damages apply for the portion of supply affected by the approved delay, with modifications communicated before bulk supply.
Sign up now to access all documents
Main Document
CATALOG Specification
GEM_GENERAL_TERMS_AND_CONDITIONS